This is not an official government website.
© 2026 PLEJ LC. All rights reserved.
Congressional Daily Record
This section covers nominations, confirmations, or other executive branch business. It mentions committees such as Committee on Agriculture.
Official title: EXECUTIVE COMMUNICATIONS, ETC.
Issued
April 27, 2026
house side of the record
People
0
No members linked from this section
Legislation
0
No linked legislation in this section
Committees
3
Committees connected to this section
Senate Holds
0
No hold activity linked here
Source Document
Connected Data
1 Helpful Term
Executive business
Senate business involving nominations, treaties, and executive branch communications rather than ordinary bills.
Source Control
Reader mode is for comprehension. The linked government PDF is the official published source.
Download official House Record PDFReturn to issue contextthe Speaker's table and referred as follows:
EC-3427. A letter from the Secretary, Commodity Futures
Trading Commission, transmitting the Commission's Major final
rule — Application of the Federal Securities Laws to Certain
Types of Crypto Assets and Certain Transactions Involving
Crypto Assets (RIN: 3038-AF67) received April 9, 2026,
pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec.
251; (110 Stat. 868); to the Committee on Agriculture.
EC-3428. A letter from the Counsel, Chief Counsel's Office,
Office of the Comptroller of the Currency, Department of the
Treasury, transmitting the Department's recission of final
interagency guidance — Leveraged Lending: Interagency
Statement on Recission of Interagency Leveraged Lending
Guidance Issuances received March 31, 2026, pursuant to 5
U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat.
868); to the Committee on Financial Services.
EC-3429. A letter from the DAA, Diversion Control Division,
DEA, Department of Justice, transmitting the Department's
final rule — Definition of “Cannabimimetic Agents” and
Assignment of an Administration Controlled Substances Code
Number for All “Cannabimimetic Agents” [Docket No.: DEA-
368] received April 7, 2026, pursuant to 5 U.S.C.
801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868);
to the Committee on Energy and Commerce.
EC-3430. A letter from the Deputy Assistant Administrator,
Diversion Control Division, DEA, Department of Justice,
transmitting the Administration's final rule — Registering
Emergency Medical Services Agencies Under the Protecting
Patient Access to Emergency Medications Act of 2017 [Docket
No.: DEA-377] (RIN: 1117-AB37) received April 7, 2026,
pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec.
251; (110 Stat. 868); to the Committee on Energy and
Commerce.
EC-3431. A letter from the DAA, Diversion Control Division,
DEA, Department of Justice, transmitting the Department's
final amendment — Schedules of Controlled Substances:
Placement of N-Desethyl Isotonitazene and N-Piperidinyl
Etonitazene in Schedule I [Docket No.: DEA-1143] received
April 7, 2026, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law
104-121, Sec. 251; (110 Stat. 868); to the Committee on
Energy and Commerce.
EC-3432. A letter from the DAA, Diversion Control Division,
DEA, Department of Justice, transmitting the Department's
final rule — Schedules of Controlled Substances: Placement
of 4-Chloromethcathinone in Schedule I [Docket No.: DEA-1246]
received April 7, 2026, pursuant to 5 U.S.C. 801(a)(1)(A);
Public Law 104-121, Sec. 251; (110 Stat. 868); to the
Committee on Energy and Commerce.
EC-3433. A letter from the DAA, Diversion Control Division,
DEA, Department of Justice, transmitting the Department's
final rule — Schedules of Controlled Substances: Placement
of 4-Fluoroamphetamine in Schedule I [Docket No.: DEA-1180]
received April 7, 2026, pursuant to 5 U.S.C. 801(a)(1)(A);
Public Law 104-121, Sec. 251; (110 Stat. 868); to the
Committee on Energy and Commerce.
EC-3434. A letter from the DAA Diversion Control, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's final rule — Specific Listing
for Dipentylone, a Currently Controlled Schedule I Substance
[Docket No.: DEA-1390] received April 7, 2026, pursuant to 5
U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat.
868); to the Committee on Energy and Commerce.
EC-3435. A letter from the DAA, Diversion Control Division,
Drug Enforcement Administration, Department of Justice,
transmitting the Department's temporary amendment —
Schedules of Controlled Substances: Temporary Placement of N-
pyrrolidino metonitazene and N-pyrrolidino protonitazene in
Schedule I [Docket No.: DEA-1337] received April 7, 2026,
pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec.
251; (110 Stat. 868); to the Committee on Energy and
Commerce.
EC-3436. A letter from the DAA, Diversion Control Division,
Drug Enforcement Administration, Department of Justice,
transmitting the Department's temporary scheduling
order — Schedules of Controlled Substances: Extension of
Temporary Placement of MDMB-4en-PINACA in Schedule I of the
Controlled Substances Act [Docket No.: DEA-1356] received
April 7, 2026, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law
104-121, Sec. 251; (110 Stat. 868); to the Committee on
Energy and Commerce.
EC-3437. A letter from the DAA, Diversion Control, Drug
Enforcement Administration, Department of Justice,
transmitting the Department's final rule — Controlled
Substances Ordering System (CSOS) Modernization [Docket No.:
DEA-732] (RIN: 1117-AB79) received April 7, 2026, pursuant to
5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110
Stat. 868); to the Committee on Energy and Commerce.
EC-3438. A letter from the General Counsel, Federal Energy
Regulatory Commission, transmitting the Commission's final
rule — Virtualization Reliability Standards [Docket No.:
RM24-8-000; Order No. 919] received March 31, 2026, pursuant
to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 251; (110
Stat. 868); to the Committee on Energy and Commerce.
EC-3439. A letter from the Assistant General Counsel,
Office of the General Counsel, Federal Communications
Commission, transmitting the Commission's final rule —
Modernizing Suspension and Debarment Rules [Docket No.: GN
19-309] received April 9, 2026, pursuant to 5 U.S.C.
801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868);
to the Committee on Energy and Commerce.
EC-3440. A letter from the Chief Judge, Superior Court of
the District of Columbia, transmitting the 2025 Family Court
Annual Report, pursuant to Public Law 107-114, Sec. 4(a);
(115 Stat. 2111); to the Committee on Oversight and
Government Reform.
EC-3441. A letter from the Charmian, Nuclear Regulatory
Commission, transmitting the Commission's FY 2025 No FEAR Act
Report, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-
121, Sec. 251; (110 Stat. 868); to the Committee on Oversight
and Government Reform.
EC-3442. A letter from the Director, Office of External
Affairs and Communications, National Credit Union
Administration, transmitting the Office's 2025 Annual
Performance Plan, pursuant to 31 U.S.C. 1115(b); Public Law
111-352, Sec. 3; (124 Stat. 3868); to the Committee on
Oversight and Government Reform.
EC-3443. A letter from the Acting Chief, Ethics
Transparency and Integrity Branch, Office of Government
Ethics, transmitting the Office's Strategic Plan,
Congressional Budget Justification, Annual Performance Plan,
and Annual Performance Report for Fiscal Years 2026 — 2030,
pursuant to 31 U.S.C. 1115(b); Public Law 111-352, Sec. 3;
(124 Stat. 3868) and 5 U.S.C. 306(a); Public Law 103-62, Sec.
3 (as amended by Public Law 111-352, Sec. 2); (124 Stat.
3866); to the Committee on Oversight and Government Reform.
EC-3444. A letter from the Director, Office of Personnel
Management, transmitting the Office's FY 2027 Congressional
Budget Justification; to the Committee on Oversight and
Government Reform.
EC-3445. A letter from the Research Director,
Administrative Conference of the United States, transmitting
the Conference's Equal Access to Justice Act Awards: Fiscal
Year 2025, pursuant to 28 U.S.C. 2412(d)(5)(A); Public Law
116-9, Sec. 4201(a)(2); (133 Stat. 763); to the Committee on
the Judiciary.